Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Author(s) -
Kathleen Chiotos,
Molly Hayes,
David W. Kimberlin,
Sarah Bruyn Jones,
Scott H. James,
Swetha Pinninti,
April Yarbrough,
Mark J. Abzug,
Christine E. MacBrayne,
Vijaya L Soma,
Daniel E. Dulek,
Surabhi B Vora,
Alpana Waghmare,
Joshua Wolf,
Rosemary Olivero,
Steven P Grapentine,
Rachel L Wattier,
Laura L. Bio,
Shane J. Cross,
Nicholas O. Dillman,
Kevin J. Downes,
Kathryn Timberlake,
Jennifer L. Young,
Rachel C. Orscheln,
Pranita D. Tamma,
Hayden T. Schwenk,
Philip Zachariah,
Margaret Aldrich,
David L. Goldman,
Helen Groves,
Gabriella S Lamb,
Alison C. Tribble,
Adam L. Hersh,
Emily A. Thorell,
Mark R. Denison,
Adam J. Ratner,
Jason G. Newland,
Mari Nakamura
Publication year - 2020
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piaa045
Subject(s) - medicine , coronavirus , covid-19 , betacoronavirus , pandemic , virology , disease , respiratory system , intensive care medicine , pediatrics , outbreak , infectious disease (medical specialty)
Although coronavirus disease 2019 (COVID-19) is mild in nearly all children, a small proportion of pediatric patients develop severe or critical illness. Guidance is therefore needed regarding use of agents with potential activity against severe acute respiratory syndrome coronavirus 2 in pediatrics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom